Kainos Group PLC (KNOS)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 1,317.00 |
|---|---|
| 52-week range | 686.00 – 1,324.00 |
| Return, 1 month / 3 months | +7.3% / +66.8% |
| Return, 1 year / 3 years | +42.3% / +29.7% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 41.8% |
| Worst drawdown (1 year) | -41.3% |
| Average daily value traded | 499.94M GBX |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kainos Group is a digital technology company based in Belfast, Northern Ireland. It helps organisations in the public, healthcare and commercial sectors modernise their systems, providing consulting and engineering services for cloud platforms and enterprise software, including implementation work for Workday. Kainos also develops its own software products, such as an electronic medical records system used by healthcare providers. Its customers include government bodies, hospitals and private businesses seeking to digitise their operations and improve how they deliver services.
The shares are listed on the London Exchange in UK under the code KNOS, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kainos Group PLC (KNOS) trades on the London Exchange in UK. It last closed at GBX 1,317.00 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 218 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 42.3% and over the last three months it rose 66.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 96 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 45.1% | ||
| From 52-week high | -0.5% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 66.8% | ||
| 6-month return | 60.5% | ||
| 12-month return, skipping the last month | 32.7% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.3% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 499.94M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.5% |
|---|---|
| 1 month | +7.3% |
| 3 months | +66.8% |
| 6 months | +60.5% |
| 1 year | +42.3% |
| 3 years | +29.7% |
| 5 years | −24.9% |
Signals
| 50-day / 200-day average | 1,213.11 / 907.88 |
|---|---|
| Golden / death cross (60 days) | Golden, 43 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 43.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Oct 2026 | GBP 0.1980 |
| 20 Nov 2025 | GBP 0.0980 |
| 2 Oct 2025 | GBP 0.1910 |
| 21 Nov 2024 | GBP 0.0930 |
| 3 Oct 2024 | GBP 0.1910 |
| 23 Nov 2023 | GBP 0.0820 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.